Correlation Engine 2.0
Clear Search sequence regions

  • dapagliflozin (2)
  • glycycoumarin (3)
  • herbal (1)
  • herbal medicines (1)
  • human (1)
  • human ugt1a9 (1)
  • isoforms (2)
  • liver (1)
  • rats (1)
  • UGT1A9 (10)
  • Sizes of these terms reflect their relevance to your search.

    UDP-glucuronosyltransferase 1A9 (UGT1A9) is one of the most important UGT isoforms, and plays an important role in the metabolic elimination of therapeutic drugs via glucuronidation. Herbal medicines affecting the activity of UGT1A9 may influence the metabolism of related drugs, thus causing herb-drug interactions and even adverse effects. However, few methods are available to evaluate the activity of UGT1A9. In this study, a natural product glabrone was discovered as an isoform-specific probe substrate for UGT1A9. The Vmax and Km values of glabrone were 362.6 nmol/min/mg protein and 17.2 μM for human liver microsomes (HLMs), and 382.3 nmol/min/mg protein and 16.6 μM for recombinant human UGT1A9, respectively. Glabrone 7-O-glucuronide, the UGT1A9 metabolite of glabrone, was prepared by using a plant glucuronosyltransferase UGT88D1, and the structure was identified by NMR spectroscopy. Using glabrone as a probe, we established a rapid HPLC method to screen UGT1A9 inhibitors from 54 natural products isolated from the Chinese herbal medicine licorice. Among them, glycycoumarin was found as a potent UGT1A9 inhibitor with an IC50 value of 6.04 μM. In rats, the pretreatment of glycycoumarin (4 mg/kg, i.p.) for 3 days could remarkably increase the plasma concentrations of dapagliflozin while decrease the concentrations of dapagliflozin-O-glucuronide after administration of dapagliflozin (1 mg/kg, i.v.), which is mainly metabolized by UGT1A9. The results indicated the potential risk of herb-drug interactions between licorice and UGT1A9-metabolizing drugs. Copyright © 2021. Published by Elsevier B.V.


    Yi Kuang, Yue Chai, Lulu Xu, Zilong Wang, Lei Liang, Xue Qiao, Min Ye. Glabrone as a specific UGT1A9 probe substrate and its application in discovering the inhibitor glycycoumarin. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2021 Jun 01;161:105786

    PMID: 33684484

    View Full Text